AR and posterior cortical atrophy: Since ASC-J9® can suppress PCa cell invasion, which contrasts with the current antiandrogens Casodex or Enz that increase the PCa cell invasion in multiple PCa cells [9, 22–25], it will be interesting to see if ASC-J9® can also function via a non-AR mechanism to suppress the PCa cell invasion.